Key result
An efficient synthetic route to (+)-ambrisentan achieved a 47% overall yield with >99.5% purity and 99.8% enantiomeric excess on a 100-g scale without column purification.
The study describes an efficient and robust synthetic route to produce (+)-ambrisentan with high purity and yield.
May improve ambrisentan supply for PAH; leaves open whether the route affects access, cost, or practice.
An efficient and robust synthetic route to (+)-ambrisentan ((+)-AMB) was designed by recycling the unwanted isomer from the resolution mother liquors. The racemization of AMB in the absence of either acid or base in the given solvents was reported. The recovery process was developed to produce racemates with purities over 99.5%. The mechanism of the formation of the process-related impurities of (+)-AMB is also discussed in detail. (+)-AMB was obtained in 47% overall yield with >99.5% purity and 99.8% e.e. by chiral resolution with only one recycling of the mother liquors on a 100-g scale without column purification.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2018) studied this question. (+)-Ambrisentan synthesis was evaluated on Overall yield and purity of (+)-ambrisentan. An efficient synthetic route to (+)-ambrisentan achieved a 47% overall yield with >99.5% purity and 99.8% enantiomeric excess on a 100-g scale without column purification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: